PDS Biotechnology

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$0
$0
$0
$0
Gross Profit
-15
-14
-14
-14
EBITDA
-8,669
-10,083
-10,392
-10,519
EBIT
-8,684
-10,097
-10,406
-10,534
Net Income
-8,327
-10,603
-10,898
-10,849
Net Change In Cash
0
0
0
0
Free Cash Flow
-8,886
-9,938
-8,457
-7,175
Cash
57,733
66,634
56,560
54,251
Basic Shares
36,693
34,815
31,669
30,910

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-57
-49
-246
-176
EBITDA
-42,987
-40,737
-21,433
-14,831
EBIT
-43,045
-40,786
-21,680
-15,008
Net Income
-42,942
-40,854
-16,918
-14,847
Net Change In Cash
0
0
0
0
Cost of Revenue
8,577
16,677
Free Cash Flow
-33,636
-25,709
-12,486
-13,149
Cash
56,560
73,820
65,242
28,839
Basic Shares
30,952
28,599
25,597
16,745

Earnings Calls

Quarter EPS
2024-06-30
-$0.23
2024-03-31
-$0.30
2023-12-31
-$0.35
2023-09-30
-$0.35